ARPA-H, US FDA Discuss Incentives For Game-Changing Health Projects

Because the Advanced Research Projects Agency for Health can reimburse FDA for services, the two agencies are discussing what that could be available, such as priority assessments, when the projects reach the application stage.

incentive magnet
What incentives could the FDA offer to speed ARPA-H projects to market? • Source: Shutterstock

The big health care ideas that ARPA-H is betting on may get incentives from the US Food and Drug Administration should they reach that development milestone.

What the Advanced Research Projects Agency for Health could offer its project sponsors is unclear, but the idea may

More from R&D

More from Pink Sheet

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

FDA Use Of Artificial Intelligence Will Help US Retain Biotech Leadership

 

At a House subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. rebutted lawmaker concerns that NIH cuts will drive research and scientists to other countries and said he does not want to advise parents on vaccinating children for measles, chickenpox or polio.